McKesson (MCK) Expected to Release Quarterly Earnings on Wednesday

Posted by George Bondi on Jul 29th, 2026

McKesson (NYSE:MCK – Get Free Report) is expected to be issuing its Q1 2027 results after the market closes on Wednesday, August 5th. Analysts expect McKesson to announce earnings of $9.56 per share and revenue of $103.8786 billion for the quarter. McKesson has set its FY 2027 guidance at 43.800-44.600 EPS. Individuals are encouraged to explore the company’s upcoming Q1 2027 earning report for the latest details on the call scheduled for Wednesday, August 5, 2026 at 4:30 PM ET.

McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Thursday, May 7th. The company reported $11.69 EPS for the quarter, topping the consensus estimate of $11.56 by $0.13. The firm had revenue of $96.30 billion for the quarter, compared to the consensus estimate of $101.35 billion. McKesson had a net margin of 1.18% and a negative return on equity of 345.35%. The business’s quarterly revenue was up 6.0% on a year-over-year basis. During the same quarter last year, the firm posted $10.12 EPS. On average, analysts expect McKesson to post $44 EPS for the current fiscal year and $50 EPS for the next fiscal year.

McKesson Price Performance

McKesson stock opened at $891.37 on Wednesday. McKesson has a fifty-two week low of $637.00 and a fifty-two week high of $999.00. The firm has a fifty day moving average price of $784.12 and a two-hundred day moving average price of $839.21. The firm has a market cap of $104.36 billion, a price-to-earnings ratio of 23.17, a P/E/G ratio of 1.40 and a beta of 0.31.

McKesson Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Stockholders of record on Tuesday, September 1st will be paid a $0.94 dividend. The ex-dividend date is Tuesday, September 1st. This is a boost from McKesson’s previous quarterly dividend of $0.82. This represents a $3.76 dividend on an annualized basis and a dividend yield of 0.4%. McKesson’s dividend payout ratio is presently 8.53%.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,463 shares of the firm’s stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $793.56, for a total transaction of $6,715,898.28. Following the completion of the transaction, the chief executive officer owned 5,919 shares in the company, valued at $4,697,081.64. This trade represents a 58.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 133 shares of the company’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $764.00, for a total value of $101,612.00. Following the completion of the sale, the chief accounting officer owned 632 shares in the company, valued at approximately $482,848. This represents a 17.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 28,748 shares of company stock worth $22,262,035. Corporate insiders own 0.06% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in MCK. University of Texas Texas AM Investment Management Co. acquired a new stake in shares of McKesson in the 4th quarter valued at $25,000. Swiss RE Ltd. bought a new position in McKesson during the 4th quarter valued at about $26,000. State of Wyoming acquired a new position in McKesson in the second quarter valued at about $29,000. Birchwood Financial Partners Inc. bought a new stake in McKesson during the fourth quarter worth about $33,000. Finally, Kemnay Advisory Services Inc. bought a new stake in McKesson during the fourth quarter worth about $39,000. 85.07% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Citigroup boosted their price objective on McKesson from $945.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Friday. Wells Fargo & Company dropped their price target on McKesson from $925.00 to $812.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 12th. Barclays cut their price target on McKesson from $1,050.00 to $925.00 and set an “overweight” rating for the company in a report on Wednesday, June 10th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $875.00 target price on shares of McKesson in a research report on Friday, May 8th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of McKesson from $1,107.00 to $1,015.00 and set an “overweight” rating on the stock in a report on Friday, May 8th. Fourteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, McKesson has an average rating of “Moderate Buy” and an average target price of $962.67.

Check Out Our Latest Stock Analysis on MCK

About McKesson

(Get Free Report)

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.